Affiliation: Kyoto University
- A 1-μT extremely low-frequency electromagnetic field vs. sham control for mild-to-moderate hypertension: a double-blind, randomized studyTsutomu Nishimura
Department of Clinical Trial Design and Management, Translational Research Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Hypertens Res 34:372-7. 2011..There were no adverse events other than mild paresthesia of the hands of two subjects in the ELF-EMF group. Our results suggest that repeated exposure to an ELF-EMF has a BP-lowering effect on humans with mild-to-moderate hypertension...
- Lizards respond to an extremely low-frequency electromagnetic fieldTsutomu Nishimura
Translational Research Center, Graduate School of Medicine, Kyoto University, Shogoin kawahara cho 54, Sakyo ku, Kyoto, 606 8507, Japan
J Exp Biol 213:1985-90. 2010..Our experiments suggest that (1) lizards perceive EMFs and (2) the parietal eye may be involved in light-dependent magnetoreceptive responses...
- The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgeryTakayoshi Kiba
Outpatient Oncology Unit, Kyoto University Hospital, Kyoto, Japan
BMC Cancer 8:323. 2008..Previous studies have shown that patients with estrogen receptor (ER) positive cancers have a better prognosis than patients whose cancers do not have these receptors...
- Interstitial lung disease in gefitinib-treated Japanese patients with non-small cell lung cancer - a retrospective analysis: JMTO LC03-02Masatsugu Nakagawa
Department of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, Kyoto, Japan
BMC Res Notes 2:157. 2009..Future studies should be aimed at identifying factors indicating that a patient has a high probability of receiving benefit from gefitinib and a low risk of developing ILD...
- Prevalence and incidence of anemia in Japanese cancer patients receiving outpatient chemotherapyToshiyuki Kitano
Department of Translational Clinical Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Int J Hematol 86:37-41. 2007..Better recognition and management of cancer-related anemia are required in Japan. To this end, randomized controlled trials evaluating the effects of erythropoietic agents on patients' survival and quality of life are necessary...